Cardizem and Hydroxyurea drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cardizem (diltiazem hydrochloride) and Hydroxyurea (hydroxyurea). Common drug interactions include cryptococcosis among females and blood urine present among males.

The phase IV clinical study analyzes what interactions people have when they take Cardizem and Hydroxyurea. It is created by eHealthMe based on reports of 42 people who take the same drugs from the FDA, and is updated regularly.

What is Cardizem?

Cardizem has active ingredients of diltiazem hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 28,014 Cardizem users. Check the latest studies of Cardizem.

What is Hydroxyurea?

Hydroxyurea has active ingredients of hydroxyurea. It is often used in polycythemia vera. eHealthMe is studying from 17,240 Hydroxyurea users. Check the latest studies of Hydroxyurea.



On Aug, 01, 2026

42 people who take Cardizem and Hydroxyurea together, and have interactions are studied.

Cardizem and Hydroxyurea drug interactions.

What are the common drug interactions of Cardizem and Hydroxyurea, by gender? *:

female:

  1. Cryptococcosis (potentially fatal fungal disease)
  2. Decreased interest
  3. Dizziness
  4. Drug ineffective
  5. Dyspnoea (difficult or laboured respiration)
  6. Fatigue (feeling of tiredness)
  7. Grand mal convulsion (a type of generalized seizure that affects the entire brain)
  8. Hip arthroplasty
  9. Lethargy (tiredness)
  10. Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)

male:

  1. Blood urine present
  2. Diarrhoea
  3. Lymphoedema (localized fluid retention and tissue swelling)
  4. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  5. Myocardial ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)
  6. Nephrolithiasis (calculi in the kidneys)
  7. Platelet count decreased
  8. Renal failure (kidney dysfunction)
  9. Chronic kidney disease
  10. Dyspnoea (difficult or laboured respiration)

What are the common drug interactions of Cardizem and Hydroxyurea, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Joint swelling
  2. Oedema peripheral (superficial swelling)
  3. Palpitations (feelings or sensations that your heart is pounding or racing)

50-59:

  1. Fatigue (feeling of tiredness)
  2. Bladder cyst
  3. Blood urine present
  4. Decreased activity
  5. Depression
  6. Difficulty in walking
  7. Feeling jittery
  8. Haemoglobin decreased
  9. Left ventricular failure (left ventricle fails to contract forcefully)
  10. Mitral valve incompetence (inefficient heart valve)

60+:

  1. Anaemia (lack of blood)
  2. Chronic kidney disease
  3. Lymphoedema (localized fluid retention and tissue swelling)
  4. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  5. Myocardial ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)
  6. Nephrolithiasis (calculi in the kidneys)
  7. Platelet count decreased
  8. Weight decreased
  9. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  10. Drug ineffective

What are the existing conditions these people have? *

  1. Primary Myelofibrosis (primary disorder of the bone marrow): 7 people, 16.67%
  2. Essential Thrombocythaemia (chronic blood cancer): 6 people, 14.29%
  3. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 11.90%
  4. Stress And Anxiety: 3 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Cardizem and Hydroxyurea?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cardizem and Hydroxyurea:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cardizem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Hydroxyurea:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cardizem and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hydroxyurea and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on diltiazem hydrochloride and hydroxyurea (the active ingredients of Cardizem and Hydroxyurea, respectively), and Cardizem and Hydroxyurea (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: